Nuevo
CagriSema (Cagrilintide 2.5 mg + Semaglutide 2.5 mg)
de Ponyon
CagriSema is a dual-compound research formulation combining Cagrilintide and Semaglutide, studied for mechanisms involving amylin and GLP-1 receptor signaling, appetite regulation, energy balance, glucose metabolism, and body-weight-related metabolic biology.
88,00 US$
1
SKU CAGRISEM-5MG_10 · Devoluciones en 30 días
CagriSema is a combination research system incorporating Cagrilintide and Semaglutide. This formulation contains Cagrilintide 2.5 mg + Semaglutide 2.5 mg.
Cagrilintide is a long-acting amylin analogue investigated in research involving amylin receptor-related signaling, appetite and satiety regulation, food intake, and energy-balance mechanisms.
Semaglutide is a GLP-1 receptor agonist studied in connection with GLP-1 receptor signaling, glucose homeostasis, insulin and glucagon regulation, gastric emptying, and energy intake.
As a combined research formulation, CagriSema provides a system for investigating interactions between amylin and GLP-1 signaling pathways and their relationships with appetite regulation, energy homeostasis, glucose metabolism, and body-weight-related metabolic mechanisms.
The safety, efficacy, or appropriate human dosing of this specific 2.5 mg + 2.5 mg formulation should not be inferred from research or approved uses involving the individual components.
Envío estándar gratis en pedidos superiores a 50 $ a EE. UU., Canadá, México y Europa. Los pedidos salen en 1 día laborable.
¿No te convence? Devuélvelo en 30 días y te reembolsamos el importe completo, aunque esté abierto.
Opiniones
Aún sin opiniones
Sé el primero en opinar sobre este producto.
Completa tu rutina
Nuevo
Nuevo
Nuevo
Nuevo
Nuevo
Nuevo
Nuevo
* Estas declaraciones no han sido evaluadas por la FDA. Este producto no está destinado a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Consulta a tu médico si estás embarazada, en periodo de lactancia, tomas medicación o tienes alguna afección.